Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 4:30 AM
Ignite Modification Date:
2025-12-25 @ 4:30 AM
NCT ID:
NCT00436618
Brief Title:
Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment
Official Title:
Phase II Trial of Everolimus (RAD001) in Relapsed/Refractory Lymphoma
Study:
NCT00436618
Protocol Section:
NCT00436618